Concord Story

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;'>CM</div>
CCM -- USA Stock  

USD 3.60  0.10  2.70%

In general, we focus on analyzing Concord (NYSE:CCM) price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Concord Medical Services daily price indicators and compare them against related drivers. Today's article will summarize Concord Medical. We will evaluate if Concord Medical shares are reasonably priced going into January.
Published over a month ago
View all stories for Concord Medical | View All Stories
Volatility may be your only friend when it comes to investing in Concord Medical
We provide trade advice to complement the prevailing expert consensus on Concord Medical Serv. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. About 18.0% of the company shares are held by company insiders. Concord Medical Serv has price-to-book (P/B) ratio of 0.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. The entity recorded a loss per share of 1.09. The firm last dividend was issued on the 23rd of December 2015. Concord Medical had 11384:10000 split on the 16th of January 2014.
The successful prediction of Concord Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Concord Medical Services, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Concord Medical based on Concord Medical hews, social hype, general headline patterns, and widely used predictive technical indicators. We also calculate exposure to Concord Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Concord Medical's related companies.

Use Technical Analysis to project Concord expected Price

Concord Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Concord Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Concord Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

How Concord utilizes its cash?

To perform a cash flow analysis of Concord Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Concord Medical is receiving and how much cash it distributes out in a given period. The Concord Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Concord Medical Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (180.44 Million)

A Deeper look at Concord

Concord Medical Serv reported the last year's revenue of 34.94 M. Reported Net Loss for the year was (47.22 M) with loss before taxes, overhead, and interest of (15.83 M).
 2017 2018 2019 2020 (projected)
Interest Expense89.96 M46.23 M28.7 M37.79 M
Gross Profit563.96 M362.03 M412.56 M431.59 M

Deferred Revenue Breakdown

Concord Medical Deferred Revenue yearly trend continues to be relatively stable with very little volatility. Deferred Revenue may rise above about 1.4 M this year. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. Concord Medical Deferred Revenue is relatively stable at the moment as compared to the past year. The company's current value of Deferred Revenue is estimated at 1.41 Million
201015.59 Million
201113.12 Million
201218.98 Million
201315.67 Million
20141.04 Million
20151.52 Million
20191.37 Million
20201.41 Million

Another 3 percent hike for Concord Medical

New skewness is at 1.46. As of the 4th of December, Concord Medical shows the mean deviation of 3.07, and Risk Adjusted Performance of (0.004447). Concord Medical Serv technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Concord Medical Services, which can be compared to its rivals. Please confirm Concord Medical Serv jensen alpha, as well as the relationship between the potential upside and skewness to decide if Concord Medical Serv is priced correctly, providing market reflects its regular price of 2.4 per share. Please also double-check Concord Medical Services total risk alpha, which is currently at (0.66) to validate the company can sustain itself at a future point.

The Current Takeaway on Concord Medical Investment

While many of the other players under the medical care facilities industry are still a bit expensive, Concord Medical may offer a potential longer-term growth to stakeholders. On the whole, as of the 4th of December 2020, we believe that Concord Medical is currently overvalued with below average probability of distress in the next two years. Our ongoing 30 days 'Buy-vs-Sell' recommendation on the company is Strong Sell.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Concord Medical Services. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to